These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 33368399)

  • 1. Plausibility and redundancy analysis to select FDG-PET textural features in non-small cell lung cancer.
    Pfaehler E; Mesotten L; Zhovannik I; Pieplenbosch S; Thomeer M; Vanhove K; Adriaensens P; Boellaard R
    Med Phys; 2021 Mar; 48(3):1226-1238. PubMed ID: 33368399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
    Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
    J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graph Neural Network Model for Prediction of Non-Small Cell Lung Cancer Lymph Node Metastasis Using Protein-Protein Interaction Network and
    Ju H; Kim K; Kim BI; Woo SK
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can alternative PET reconstruction schemes improve the prognostic value of radiomic features in non-small cell lung cancer?
    Tankyevych O; Tixier F; Antonorsi N; Filali Razzouki A; Mondon R; Pinto-Leite T; Visvikis D; Hatt M; Cheze Le Rest C
    Methods; 2021 Apr; 188():73-83. PubMed ID: 33197567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
    Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
    Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatment
    Ahn HK; Lee H; Kim SG; Hyun SH
    Clin Radiol; 2019 Jun; 74(6):467-473. PubMed ID: 30898382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
    Carvalho S; Leijenaar RTH; Troost EGC; van Timmeren JE; Oberije C; van Elmpt W; de Geus-Oei LF; Bussink J; Lambin P
    PLoS One; 2018; 13(3):e0192859. PubMed ID: 29494598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
    Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
    Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
    Pyka T; Bundschuh RA; Andratschke N; Mayer B; Specht HM; Papp L; Zsótér N; Essler M
    Radiat Oncol; 2015 Apr; 10():100. PubMed ID: 25900186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.
    Kirienko M; Cozzi L; Antunovic L; Lozza L; Fogliata A; Voulaz E; Rossi A; Chiti A; Sollini M
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):207-217. PubMed ID: 28944403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding the temporal domain to PET radiomic features.
    Noortman WA; Vriens D; Slump CH; Bussink J; Meijer TWH; de Geus-Oei LF; van Velden FHP
    PLoS One; 2020; 15(9):e0239438. PubMed ID: 32966313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?
    Piñeiro-Fiel M; Moscoso A; Lado-Cacheiro L; Pombo-Pasín M; Rey-Bretal D; Gómez-Lado N; Mondelo-García C; Silva-Rodríguez J; Pubul V; Sánchez M; Ruibal Á; Aguiar P
    Eur Radiol; 2021 Jun; 31(6):4156-4165. PubMed ID: 33247345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and reproducibility of computed tomography radiomic features extracted from peritumoral regions of lung cancer lesions.
    Tunali I; Hall LO; Napel S; Cherezov D; Guvenis A; Gillies RJ; Schabath MB
    Med Phys; 2019 Nov; 46(11):5075-5085. PubMed ID: 31494946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235.
    Ohri N; Duan F; Snyder BS; Wei B; Machtay M; Alavi A; Siegel BA; Johnson DW; Bradley JD; DeNittis A; Werner-Wasik M; El Naqa I
    J Nucl Med; 2016 Jun; 57(6):842-8. PubMed ID: 26912429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of [
    Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q
    Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment
    Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
    J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer.
    Duan C; Chaovalitwongse WA; Bai F; Hippe DS; Wang S; Thammasorn P; Pierce LA; Liu X; You J; Miyaoka RS; Vesselle HJ; Kinahan PE; Rengan R; Zeng J; Bowen SR
    Phys Med Biol; 2020 Oct; 65(20):205007. PubMed ID: 33027064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.